Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $55.88 USD
Change Today +1.22 / 2.23%
Volume 197.2K
MDSO On Other Exchanges
Symbol
Exchange
NASDAQ GS
As of 12:16 PM 05/4/15 All times are local (Market data is delayed by at least 15 minutes).

medidata solutions inc (MDSO) Snapshot

Open
$54.69
Previous Close
$54.66
Day High
$56.49
Day Low
$54.46
52 Week High
04/27/15 - $58.97
52 Week Low
05/7/14 - $32.10
Market Cap
3.1B
Average Volume 10 Days
949.3K
EPS TTM
$0.21
Shares Outstanding
55.2M
EX-Date
--
P/E TM
268.4x
Dividend
--
Dividend Yield
--
Current Stock Chart for MEDIDATA SOLUTIONS INC (MDSO)

medidata solutions inc (MDSO) Related Bloomberg News

View More Bloomberg News

medidata solutions inc (MDSO) Related Businessweek News

No Related Businessweek News Found

medidata solutions inc (MDSO) Details

Medidata Solutions, Inc. provides cloud-based clinical development solutions for life sciences in the United States and internationally. The company offers applications and data analytics for clinical development. It offers Medidata Rave, a platform for capturing, managing, and reporting clinical data; Medidata CTMS, a clinical trial management solution that streamlines operational workflows; Medidata Designer, which enhances the efficiency of clinical trial start-up; Medidata Insights, a clinical business analytics platform; and Medidata Balance, a randomization and trial supply management solution. The company also provides Medidata Patient Cloud application for electronic patient-reported outcome; Medidata Grants Manager, which enables to develop and manage trial budgets; Medidata contract research organization (CRO) Contractor, an analytical tool for CRO outsourcing, budgeting, and negotiation; and Medidata SQM, a set of cloud-based site quality management dashboards. In addition, it offers Medidata Coder that provides medical coding and synonym management solutions; Medidata Safety Gateway, which offers a solution for collecting and transmitting adverse events and related data from the EDC system; and Medidata Targeted SDV that provides auditable and scalable solutions, as well as offers hosting, support, and professional services. Medidata Solutions, Inc. markets and sells its cloud-based solutions through direct sales force, as well as through relationships with CROs and other strategic partners. The company serves pharmaceutical, biotechnology, medical device, and diagnostics companies; and academic institutions, contract research organizations, and other entities engaged in clinical trials. Medidata Solutions, Inc. was founded in 1999 and is headquartered in New York, New York.

1,077 Employees
Last Reported Date: 03/2/15
Founded in 1999

medidata solutions inc (MDSO) Top Compensated Officers

Co-Founder, Chairman and Chief Executive Offi...
Total Annual Compensation: $497.9K
Co-Founder, President, Director and President...
Total Annual Compensation: $497.9K
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $339.2K
Chief Operating Officer
Total Annual Compensation: $112.5K
Chief Commercial Officer
Total Annual Compensation: $325.0K
Compensation as of Fiscal Year 2014.

medidata solutions inc (MDSO) Key Developments

Medidata Solutions, Inc. Reports Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2015; Provides Earnings Guidance for the Full Year of 2015

Medidata Solutions, Inc. reported unaudited consolidated earnings results for the first quarter ended March 31, 2015. For the quarter, the company reported total revenues of $92,440,000 compared with $76,640,000 for the same period last year. Operating income was $3,466,000 compared to $274,000 for the same period last year. Income before income taxes was $8,000 compared with loss before income taxes of $3,078,000 for the same period last year. Net income was $157,000 or $0.00 diluted per share compared with net loss of $1,815,000 or $0.03 diluted per share for the same period last year. Non-GAAP operating income was $17,689,000 compared with $12,508,000 for the same period last year. Adjusted non-GAAP net income was $9,221,000 or $0.17 diluted per share compared with $5,923,000 or $0.11 diluted per share for the same period last year. Net cash provided by operating activities was $16,865,000 compared with net cash used in operating activities of $6,286,000 for the same period last year. Purchase of furniture, fixtures and equipment was $3,451,000 compared with $7,048,000 for the same period last year. For the full year 2015, the company's guidance provided on February 5, 2015 remains unchanged. Revenues are expected between $392.0 and $412.0 million, representing between 17% and 23% year-over-year growth. Non-GAAP operating income expected between $90.0 and $96.0 million. Based on current estimates, this would equate to GAAP operating income between $33.0 and $35.5 million. Adjusted non-GAAP net income, which includes the tax affected adjustments primarily from stock-based compensation, non-cash interest expense associated with convertible senior notes and amortization at a 40% effective tax rate, between $47.0 and $50.5 million. Based on current estimates, this would equate to GAAP net income between $11.5 and $13.0 million.

Medidata Announces Executive Changes

Medidata announced that Rouven Bergmann is joining the company as Chief Financial Officer effective May 18, 2015. Bergmann’s financial and operational experience managing a multibillion-dollar software business extends the breadth and depth of Medidata’s leadership team. As Chief Financial Officer of SAP North America, Bergmann was responsible for overseeing all financial activities for SAP’s large business unit. His key accomplishments include driving SAP’s transition from a traditional licensing model to SaaS (software-as-a-service) and transformational acquisition integrations. Since joining SAP in 2005, Bergmann has served as chief operating officer for SAP’s global R&D organization, as well as in key leadership roles in Waldorf, Germany; Bangalore, India; and Palo Alto. Cory Douglas, Medidata’s current Chief Financial Officer, will pursue opportunities outside of Medidata by mutual agreement upon Bergmann’s start.

Medidata Solutions, Inc. to Report Q1, 2015 Results on Apr 23, 2015

Medidata Solutions, Inc. announced that they will report Q1, 2015 results at 8:00 AM, US Eastern Standard Time on Apr 23, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MDSO:US $55.88 USD +1.22

MDSO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
DATATRAK International Inc $6.90 USD -0.45
Enzo Biochem Inc $2.79 USD +0.01
Luminex Corp $15.79 USD -0.05
OmniComm Systems Inc $0.19 USD -0.02
Oracle Corp $44.78 USD +0.4128
View Industry Companies
 

Industry Analysis

MDSO

Industry Average

Valuation MDSO Industry Range
Price/Earnings 100.0x
Price/Sales 8.3x
Price/Book 10.7x
Price/Cash Flow 374.0x
TEV/Sales 7.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDIDATA SOLUTIONS INC, please visit www.mdsol.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.